A histopathological profile of gestational trophoblastic disease in the Madinah Region of Saudi Arabia: A single institute experience
- PMID: 35975372
- DOI: 10.4103/njcp.njcp_2049_21
A histopathological profile of gestational trophoblastic disease in the Madinah Region of Saudi Arabia: A single institute experience
Abstract
Background: Gestational trophoblastic disease (GTD) is a rare and often curable group of diseases that has a large range of morphological features, sometimes making the diagnosis difficult.
Aim: The objectives of this study were to evaluate the pathological frequency and histopathological profile of GTD diagnoses in the Madinah region of Saudi Arabia (KSA).
Materials and methods: The computerized record of the pathology department of the Maternity and Children's Hospital (MCH) in Madinah, KSA, was reviewed from July 2015 to June 2021. During the study period, all the pathology reports with diagnosis of GTD were included in the study for the following parameters: age, nationality, year of diagnosis, type of GTD, and total annual number of pregnancies. Simple statistical analysis was performed, utilizing the SPSS-19 software.
Results: A total of 289 cases of GTD were diagnosed during the study period. The mean age was 33.47 ± 9.3, and most of the patients (n = 106, 36.2%) were in the fourth decade [31-40 age group]. Histologically, the most common type diagnosed was Hydatidiform mole [HM] (n = 284, 98.6%), followed by three cases of trophoblastic neoplasm (1.0%) and one case of tumor-like condition called exaggerated placental site (0.3%). Complete HM (n = 53, 50%) was common in the fourth decade, whereas partial HM (n = 50, 53.8%) was common in the third decade.
Conclusion: In the Al Madinah region of KSA, the most common type of GTD in women was HM. Most GTD cases were found in women between the ages of 31 to 40 years. The frequency of GTD, its histopathological subtypes are consistent with most of the studies on GTD; however, larger studies involving multiple centers are recommended, for confirmation of present study's findings.
Keywords: Gestational trophoblastic disease; histopathological profile; hydatidiform mole; retrospective.
Conflict of interest statement
None
Similar articles
-
Gestational trophoblastic disease in the western region of Saudi Arabia (single-institute experience).Eur J Obstet Gynecol Reprod Biol. 2014 Sep;180:8-11. doi: 10.1016/j.ejogrb.2014.06.005. Epub 2014 Jun 17. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 24972119
-
Pathology of Gestational Trophoblastic Disease (GTD).Hematol Oncol Clin North Am. 2024 Dec;38(6):1191-1217. doi: 10.1016/j.hoc.2024.08.017. Epub 2024 Sep 24. Hematol Oncol Clin North Am. 2024. PMID: 39322461 Review.
-
Trends in incidence for gestational trophoblastic disease over the last 20 years in a population-based study.Gynecol Oncol. 2016 Jan;140(1):70-5. doi: 10.1016/j.ygyno.2015.11.014. Epub 2015 Nov 14. Gynecol Oncol. 2016. PMID: 26586414
-
Experience of women on the Irish National Gestational Trophoblastic Disease Registry.Eur J Obstet Gynecol Reprod Biol. 2022 May;272:206-212. doi: 10.1016/j.ejogrb.2022.03.039. Epub 2022 Mar 28. Eur J Obstet Gynecol Reprod Biol. 2022. PMID: 35367922
-
Pathology of gestational trophoblastic disease (GTD).Best Pract Res Clin Obstet Gynaecol. 2021 Jul;74:3-28. doi: 10.1016/j.bpobgyn.2021.02.005. Epub 2021 Mar 31. Best Pract Res Clin Obstet Gynaecol. 2021. PMID: 34219021 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical